Thompson Craig B. — SEC Form 4 filings

SEC reporting owner CIK 1423419. 5 Form 4 filings on record with FilingPulse; latest filed 2026-05-12.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-05-15 to 2026-05-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)Director35
REGENERON PHARMACEUTICALS, INC. (REGN)Director24

Form 4 filings — Thompson Craig B.

FiledFormIssuerReported transactionsSource
2026-05-124CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)Grant/award (A): 1,438 @ $177.62EDGAR
2026-01-064REGENERON PHARMACEUTICALS, INC. (REGN)Grant/award (A): 155 @ $0 · Grant/award (A): 1,962 (derivative) @ $0EDGAR
2025-05-234CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)Grant/award (A): 946 @ $134.98 · Grant/award (A): 2,076 (derivative) @ $134.98EDGAR
2025-01-064REGENERON PHARMACEUTICALS, INC. (REGN)Grant/award (A): 166 @ $0 · Grant/award (A): 1,958 (derivative) @ $0EDGAR
2024-05-154CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)Grant/award (A): 559 @ $228.41 · Grant/award (A): 1,311 (derivative) @ $228.41EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1423419 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →